Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Role of Acute Myeloid Leukemia Derived-Extracellular Vesicles in Dysregulating Normal Hematopoiesis

Ilaria Laurenzana, PhD, Stefania Trino, PhD, Daniela Lamorte, PhD, Michele Santodirocco, MD, Lazzaro Di Mauro, MD, Borazio Nazario, Antonella Caivano, Luciana De Luca, Pellegrino Musto, MD

Blood (2019) 134 (Supplement_1): 1411.

https://doi.org/10.1182/blood-2019-125544

Published: 2019

Journal Articles

Characterization and Prognostic Relevance of Circulating Microvesicles in Chronic Lymphocytic Leukemia

Luciana De Luca, Giovanni D'Arena, MD, Vittorio Simeon, PhD, Stefania Trino, PhD, Ilaria Laurenzana, PhD, Antonella Caivano, Francesco La Rocca, Oreste Villani, MD, Giovanna Mansueto, MD, Silvia Deaglio, MD PhD, Idanna Innocenti, MD, Luca Laurenti, Stefano Molica, MD, Giuseppe Pietrantuono, MD, Angelo De Stradis, Luigi Del Vecchio, MD, Pellegrino Musto, MD

Blood (2016) 128 (22): 4375.

https://doi.org/10.1182/blood.V128.22.4375.4375

Published: 2016

Journal Articles

A Pyrazolo[3,4-d]Pyrimidine Compound Reduces Fyn Phosphorylation and Induces Apoptosis in Large Granular Lymphocyte Leukemia Cells

Ilaria Laurenzana, PhD, Antonella Caivano, Francesco La Rocca, Stefania Trino, PhD, Luciana De Luca, Francesca D'Alessio, Cristina Tintori, PhD, Vittorio Simeon, PhD, Antonio Traficante, Antonella Teramo, PhD, Renato Zambello, Gianpietro Semenzato, Silvia Schenone, Maurizio Botta, PhD, Pellegrino Musto, Luigi Del Vecchio, MD

Blood (2015) 126 (23): 3254.

https://doi.org/10.1182/blood.V126.23.3254.3254

Published: 2015

Journal Articles

High Serum Levels of Extracellular Vesicles which Express Specific Markers of Malignancy Are Released in Patients with Various Types of Hematological Neoplastic Disorders

Antonella Caivano, Luciana De Luca, Ilaria Laurenzana, Francesco La Rocca, Vittorio Simeon, Stefania Trino, Annalisa Morano, Fiorella D'Auria, Pellegrino Musto, MD, Luigi Del Vecchio

Blood (2014) 124 (21): 2917.

https://doi.org/10.1182/blood.V124.21.2917.2917

Published: 2014

Journal Articles

Exposure of Cord Blood Hematopoietic Stem Cells to Bone Marrow Mesenchimal Cells-Derived Microvesicles Induces Cell Survival and Inhibition of Differentiation

Luciana De Luca, Stefania Trino, Vittorio Simeon, Ilaria Laurenzana, Stefania Raimondo, Marina Podestà, Michele Santodirocco, Lazzaro Di Mauro, Francesco La Rocca, Antonella Caivano, Annalisa Morano, Luigi Del Vecchio, Francesco Frassoni, Daniela Cilloni, Pellegrino Musto, MD

Blood (2014) 124 (21): 4364.

https://doi.org/10.1182/blood.V124.21.4364.4364

Published: 2014

Journal Articles

EphA3 As a Molecular Target In Multiple Myeloma: Opportunity For a Novel Therapeutic Approach With a Specific Monoclonal Antibody

Blood (2013) 122 (21): 3211.

https://doi.org/10.1182/blood.V122.21.3211.3211

Published: 2013

Journal Articles

Down-Regulation of BMI-1 Is a New Marker of Sensitivity to Mdm2 Inhibition in B-Acute Lymphoblastic Leukemia.

Ilaria Iacobucci, Daniela Erriquez, Anna Ferrari, Cristina Papayannidis, Claudia Venturi, Stefania Trino, Viviana Guadagnuolo, Annalisa Lonetti, Federica Cattina, Emanuela Ottaviani, Maria Chiara Abbenante, Sarah Parisi, Simona Soverini, Domenico Russo, Fabrizio Pane, Michele Baccarani, MD, Giovanni Perini, Giovanni Martinelli

Blood (2012) 120 (21): 2522.

https://doi.org/10.1182/blood.V120.21.2522.2522

Published: 2012

Journal Articles

Identification of EpHA3 As a New Potential Molecular Target in Multiple Myeloma.

Antonella Caivano, Francesco La Rocca, Alessandra Favole, PhD, Sonia Carturan, PhD, Enrico Bracco, PhD, Oreste Villani, Giuseppe Pietrantuono, Ilaria Laurenzana, Luciana De Luca, MD, Annalisa Morano, Vittorio Simeon, Stefania Trino, Simona Berardi, Antonio Basile, Angelo Vacca, Pellegrino Musto, Daniela Cilloni, MD

Blood (2012) 120 (21): 2926.

https://doi.org/10.1182/blood.V120.21.2926.2926

Published: 2012

Journal Articles

ARF Loss, a Negative Prognostic Factor in Philadelphia-Positive Acute Lymphoblastic Leukemia, May Be Efficiently Overcome by the Small Molecule MDM2 Antagonist RG7112

Ilaria Iacobucci, PhD, Federica Cattina, MD, Silvia Pomella, Annalisa Lonetti, Anna Ferrari, Cristina Papayannidis, Stefania Trino, Daniela Erriquez, Viviana Guadagnuolo, Emanuela Ottaviani, Serena Formica, Simona Soverini, Francesca Paoloni, Marco Vignetti, Domenico Russo, Giovanni Perini, Michele Baccarani, MD, Giovanni Martinelli, MD

Blood (2011) 118 (21): 2574.

https://doi.org/10.1182/blood.V118.21.2574.2574

Published: 2011

Journal Articles

BCR-ABL1 -Positive Acute Lymphoblastic Leukemia Patients Treated with Only TKI Vs Conventional Chemo Plus TKI Therapy Show Similar DNA Alterations At Relapse Targeting Key Regulators of Tumor Suppression, Cell Cycle Control, and Lymphoid/B-Cell Development,

Ilaria Iacobucci, PhD, Heike Pfifer, Annalisa Lonetti, Cristina Papayannidis, Anna Ferrari, Stefania Trino, Maria Chiara Abbenante, Sarah Parisi, Simona Soverini, Antonella Vitale, Stefania Paolini, Emanuela Ottaviani, Carmen Baldazzi, Fabrizio Pane, Michele Baccarani, MD, Oliver G. Ottmann, MD, PhD, Giovanni Martinelli, MD

Blood (2011) 118 (21): 3580.

https://doi.org/10.1182/blood.V118.21.3580.3580

Published: 2011

Journal Articles

TP53 Alterations Including Missense Mutations, Aberrant Exon-Junctions and Internal Intron Retentions Are Frequent and May Contribute to MDM2 Antagonist-Resistance in B-Acute Lymphoblastic leukemia

Ilaria Iacobucci, PhD, Anna Ferrari, Stefania Trino, Annalisa Lonetti, Cristina Papayannidis, Alberto Ferrarini, Luca Venturini, Maria Chiara Abbenante, Sarah Parisi, Federica Cattina, MD, Simona Soverini, Stefania Paolini, Domenico Russo, Marco Vignetti, Fabrizio Pane, Pellegrino Musto, Massimo Delledonne, Michele Baccarani, MD, Giovanni Martinelli, MD

Blood (2011) 118 (21): 1484.

https://doi.org/10.1182/blood.V118.21.1484.1484

Published: 2011

NARROW

Role of Acute Myeloid Leukemia Derived-Extracellular Vesicles in Dysregulating Normal Hematopoiesis

Characterization and Prognostic Relevance of Circulating Microvesicles in Chronic Lymphocytic Leukemia

A Pyrazolo[3,4-d]Pyrimidine Compound Reduces Fyn Phosphorylation and Induces Apoptosis in Large Granular Lymphocyte Leukemia Cells

High Serum Levels of Extracellular Vesicles which Express Specific Markers of Malignancy Are Released in Patients with Various Types of Hematological Neoplastic Disorders

Exposure of Cord Blood Hematopoietic Stem Cells to Bone Marrow Mesenchimal Cells-Derived Microvesicles Induces Cell Survival and Inhibition of Differentiation

EphA3 As a Molecular Target In Multiple Myeloma: Opportunity For a Novel Therapeutic Approach With a Specific Monoclonal Antibody

Down-Regulation of BMI-1 Is a New Marker of Sensitivity to Mdm2 Inhibition in B-Acute Lymphoblastic Leukemia.

Identification of EpHA3 As a New Potential Molecular Target in Multiple Myeloma.

ARF Loss, a Negative Prognostic Factor in Philadelphia-Positive Acute Lymphoblastic Leukemia, May Be Efficiently Overcome by the Small Molecule MDM2 Antagonist RG7112

BCR-ABL1 -Positive Acute Lymphoblastic Leukemia Patients Treated with Only TKI Vs Conventional Chemo Plus TKI Therapy Show Similar DNA Alterations At Relapse Targeting Key Regulators of Tumor Suppression, Cell Cycle Control, and Lymphoid/B-Cell Development,

TP53 Alterations Including Missense Mutations, Aberrant Exon-Junctions and Internal Intron Retentions Are Frequent and May Contribute to MDM2 Antagonist-Resistance in B-Acute Lymphoblastic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only